JP2015504438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504438A5 JP2015504438A5 JP2014542858A JP2014542858A JP2015504438A5 JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5 JP 2014542858 A JP2014542858 A JP 2014542858A JP 2014542858 A JP2014542858 A JP 2014542858A JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- use according
- composition
- administered
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11190826.5A EP2596806A1 (en) | 2011-11-25 | 2011-11-25 | Method for prevention of colectomy |
| EP11190826.5 | 2011-11-25 | ||
| US201261595230P | 2012-02-06 | 2012-02-06 | |
| US61/595,230 | 2012-02-06 | ||
| PCT/EP2012/073501 WO2013076262A1 (en) | 2011-11-25 | 2012-11-23 | Method for prevention of colectomy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Division JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504438A JP2015504438A (ja) | 2015-02-12 |
| JP2015504438A5 true JP2015504438A5 (enExample) | 2016-01-28 |
| JP6193248B2 JP6193248B2 (ja) | 2017-09-06 |
Family
ID=45094516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014542858A Expired - Fee Related JP6193248B2 (ja) | 2011-11-25 | 2012-11-23 | 結腸切除の予防のための方法 |
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9492516B2 (enExample) |
| EP (3) | EP2596806A1 (enExample) |
| JP (2) | JP6193248B2 (enExample) |
| CA (1) | CA2892203C (enExample) |
| CY (1) | CY1122089T1 (enExample) |
| DK (1) | DK2782602T3 (enExample) |
| ES (1) | ES2745677T3 (enExample) |
| HR (1) | HRP20191723T1 (enExample) |
| HU (1) | HUE046154T2 (enExample) |
| LT (1) | LT2782602T (enExample) |
| PL (1) | PL2782602T3 (enExample) |
| PT (1) | PT2782602T (enExample) |
| RS (1) | RS59358B1 (enExample) |
| SI (1) | SI2782602T1 (enExample) |
| SM (1) | SMT201900527T1 (enExample) |
| WO (1) | WO2013076262A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881808C (en) * | 2013-07-05 | 2021-08-17 | Sony Corporation | Transmission apparatus, transmission method, reception apparatus, and reception method |
| US20180193270A1 (en) | 2016-11-29 | 2018-07-12 | PureTech Health LLC | Exosomes for delivery of therapeutic agents |
| BR112019021520A2 (pt) | 2017-04-14 | 2020-08-04 | Tollnine, Inc. | oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune |
| GB201707503D0 (en) * | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New Therapy 3 |
| GB201707501D0 (en) * | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New therapy 2 |
| GB201807312D0 (en) | 2018-05-03 | 2018-06-20 | Index Pharmaceuticals Ab | Formulation |
| GB201818579D0 (en) * | 2018-11-14 | 2018-12-26 | Index Pharmaceuticals Ab | New therapy |
| GB201912191D0 (en) * | 2019-08-24 | 2019-10-09 | Index Pharmaceuticals Ab | New therapy |
| EP4147688A1 (en) * | 2021-09-09 | 2023-03-15 | InDex Pharmaceuticals AB | Enema formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| US5849719A (en) | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| CA2244946C (en) | 1996-01-30 | 2010-04-13 | The Regents Of The University Of California | Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| WO1998016247A1 (en) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6426334B1 (en) | 1997-04-30 | 2002-07-30 | Hybridon, Inc. | Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6809193B2 (en) * | 1997-08-13 | 2004-10-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| JP2008526249A (ja) | 2005-01-13 | 2008-07-24 | プロジェニカ・バイオファーマ・エス・アー | ｉｎｖｉｔｒｏ遺伝子タイピングのための方法および製品 |
| EP1892293A4 (en) | 2005-06-06 | 2008-12-10 | Anges Mg Inc | TRANSCRIPTION FACTOR DECOY |
| PT2179737E (pt) | 2005-07-01 | 2013-12-05 | Index Pharmaceuticals Ab | Método para modular a capacidade de resposta aos esteróides |
| SI2380584T1 (sl) * | 2005-07-01 | 2014-04-30 | Index Pharmaceuticals Ab | Imunostimulatorni postopek |
| ES2560782T3 (es) * | 2008-11-04 | 2016-02-22 | Index Pharmaceuticals Ab | Compuestos y métodos para el tratamiento de enfermedades inflamatorias del SNC |
-
2011
- 2011-11-25 EP EP11190826.5A patent/EP2596806A1/en not_active Withdrawn
-
2012
- 2012-11-23 SM SM20190527T patent/SMT201900527T1/it unknown
- 2012-11-23 WO PCT/EP2012/073501 patent/WO2013076262A1/en not_active Ceased
- 2012-11-23 SI SI201231671T patent/SI2782602T1/sl unknown
- 2012-11-23 RS RSP20191190 patent/RS59358B1/sr unknown
- 2012-11-23 CA CA2892203A patent/CA2892203C/en active Active
- 2012-11-23 EP EP12790904.2A patent/EP2782602B1/en active Active
- 2012-11-23 PT PT127909042T patent/PT2782602T/pt unknown
- 2012-11-23 DK DK12790904.2T patent/DK2782602T3/da active
- 2012-11-23 LT LTEP12790904.2T patent/LT2782602T/lt unknown
- 2012-11-23 HU HUE12790904A patent/HUE046154T2/hu unknown
- 2012-11-23 HR HRP20191723 patent/HRP20191723T1/hr unknown
- 2012-11-23 US US14/359,945 patent/US9492516B2/en not_active Expired - Fee Related
- 2012-11-23 EP EP19173912.7A patent/EP3556403A1/en not_active Withdrawn
- 2012-11-23 ES ES12790904T patent/ES2745677T3/es active Active
- 2012-11-23 PL PL12790904T patent/PL2782602T3/pl unknown
- 2012-11-23 JP JP2014542858A patent/JP6193248B2/ja not_active Expired - Fee Related
-
2016
- 2016-09-14 US US15/264,709 patent/US9795627B2/en not_active Expired - Fee Related
- 2016-11-08 JP JP2016218270A patent/JP6318221B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-21 US US15/711,228 patent/US20180015117A1/en not_active Abandoned
-
2019
- 2019-09-26 CY CY20191101013T patent/CY1122089T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20191723T1 (hr) | Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa | |
| JP2015516989A5 (enExample) | ||
| JP2016074736A5 (enExample) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2018519835A5 (enExample) | ||
| JP2015514418A5 (enExample) | ||
| JP2012516856A5 (enExample) | ||
| IL317818A (en) | Oligonucleotides to reduce PD-L1 expression | |
| JP2014513954A5 (enExample) | ||
| JP2016195616A5 (enExample) | ||
| JP2018110601A5 (enExample) | ||
| JP2014532704A5 (enExample) | ||
| MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| JP2014504857A5 (enExample) | ||
| JP2013067645A5 (enExample) | ||
| HK1200716A1 (zh) | 使用胞苷類似物的口服製劑治療癌症的方法 | |
| JP2011225596A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2016116520A5 (enExample) | ||
| JP2016508134A5 (enExample) | ||
| MX359548B (es) | Agentes de iarn modificados. | |
| JP2015514778A5 (enExample) | ||
| JP2020522244A5 (enExample) | ||
| AR084319A1 (es) | INHIBIDORES DE microARN (miARN O miR) QUE COMPRENDEN NUCLEOTIDOS BLOQUEADOS | |
| FI3166615T3 (fi) | Kelatoituja fosforotioaattinukleiinihappopolymeerejä käytettäväksi yhdistelmänä HBV-polymeraasin inhibiittorin kanssa hepatiitti B- ja hepatiitti D -virusinfektioiden hoitamiseksi |